Trial Profile
Fycompa Titration Intervals and Effects on Retention Rate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Generalised epilepsy; Partial epilepsies
- Focus Pharmacokinetics
- 16 May 2022 Status changed from active, no longer recruiting to completed.
- 26 Jul 2021 Planned End Date changed from 1 Mar 2022 to 1 Dec 2021.
- 26 Jul 2021 Status changed from recruiting to active, no longer recruiting.